sodium enoxaparin
PolandDrugs containing this active substance
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in cases of cancer, in unstable angina pectoris or after a heart attack, as well as to prevent clotting in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 20 mg ATC: B01AB05
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among others, in patients after surgical procedures, in the course of neoplastic diseases, in cases of unstable angina pectoris or after a heart attack, as well as to prevent clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 40 mg/0.4 ml ATC: B01AB05
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots in patients following surgical procedures, in the course of neoplastic diseases, in individuals with unstable angina pectoris or after a heart attack, as well as to prevent the formation of clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 60 mg ATC: B01AB05
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots in people after surgical procedures, in patients with cancer, in cases of unstable angina pectoris or after a heart attack, as well as to prevent the formation of clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 100 mg/1 ml ATC: B01AB05
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots in people after surgical procedures, in patients with cancer, in cases of immobility, in cases of unstable angina pectoris or after a heart attack, as well as to prevent the formation of clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 80 mg ATC: B01AB05
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots before and after surgical procedures, during certain diseases, in patients with cancer, in unstable angina pectoris or after a heart attack, as well as to prevent the formation of clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 300 mg ATC: B01AB05
Manufacturer: Sanofi-Aventis Deutschland GmbH
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots before and after surgical procedures, in cancer patients, in cases of unstable angina pectoris or after a heart attack, as well as to prevent the formation of clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 120 mg ATC: B01AB05
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in cases of cancer, in unstable angina pectoris or after a heart attack, as well as to prevent clotting in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 150 mg ATC: B01AB05
-
Crusia is used to treat existing blood clots and to prevent the formation of new ones. It is also used after surgical procedures, in the course of certain diseases (e.g., cancer or unstable angina pectoris), after a myocardial infarction, and to prevent the formation of clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 100 mg/ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in the case of cancer-induced clots, in unstable angina pectoris, after a myocardial infarction, and to prevent blood clotting in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 150 mg/ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in the course of diseases that limit mobility, in the case of clots caused by cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 80 mg/0.8 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots (it prevents them from growing and helps the body dissolve them) and to prevent the formation of new clots. It may be used, among other things, before and after surgery, during acute illness with limited mobility, in the case of cancer-induced clots, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 60 mg/0.6 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgical procedures, during acute illness with limited mobility, in the case of clots caused by cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 40 mg/0.4 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is also used to prevent clots after surgery, during certain diseases, after a myocardial infarction, in unstable angina pectoris, and in patients undergoing dialysis.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 20 mg/0.2 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in cases of cancer, in unstable angina pectoris or after a heart attack, as well as to prevent the formation of clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 100 mg/ml ATC: B01AB05
Manufacturer: Centre Specialites Pharmaceutiques
-
This medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in cases of cancer, in unstable angina pectoris or after a heart attack, as well as to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 40 mg/ml ATC: B01AB05
Manufacturer: Centre Specialites Pharmaceutiques
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used, among other things, before and after surgery, in cases of cancer, in unstable angina pectoris or after a heart attack, as well as to prevent clotting in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 20 mg/ml ATC: B01AB05
Manufacturer: Centre Specialites Pharmaceutiques
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used before and after surgery, during acute illness with limited mobility, in cancer patients, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 20 mg/0.2 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgical procedures, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 80 mg/0.8 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
Losmina is used to treat existing blood clots and to prevent the formation of new ones. It is prescribed, among other things, before and after surgical procedures, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 100 mg/ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
Losmina is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, during acute illness with limited mobility, in patients with cancer, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 60 mg/0.6 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among others, before and after surgery, during acute illness with limited mobility, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection in ampoule-syringe
Active substance Dosage sodium enoxaparin 40 mg/0.4 ml ATC: B01AB05
Manufacturer: Rovi Pharma Industrial Services, S.A.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used before and after surgery, in cases of cancer, in cases of limited mobility, in unstable angina pectoris, after a myocardial infarction, or to prevent clotting in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 20 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in cases of cancer, in unstable angina pectoris, after myocardial infarction, and to prevent clotting in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 40 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used before and after surgery, in cases of diseases that limit mobility, during cancer treatment, in unstable angina pectoris, after a myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 60 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used, among other things, before and after surgery, in the course of neoplastic diseases, in unstable angina pectoris, after myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 80 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used before and after surgery, in cases of limited mobility, during cancer treatment, in unstable angina pectoris, after myocardial infarction, and to prevent blood clotting in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 100 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It is used, among other things, before and after surgery, in cases of cancer, unstable angina pectoris, after myocardial infarction, and to prevent clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 120 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.
-
The medicine is used to treat existing blood clots and to prevent the formation of new ones. It may be used before and after surgery, in cancerous diseases, in unstable angina pectoris, after a myocardial infarction, and in individuals with limited mobility. It is also used to prevent the formation of clots in dialyzer tubing.
Form: solution for injection
Active substance Dosage sodium enoxaparin 150 mg ATC: B01AB05
Manufacturer: SciencePharm Ltd.